Magrit Phase Iii Trial: Mage-A3 Antigen-Specific Cancer Immunotherapy (Asci) As Adjuvant Therapy In Patients With Completely Resected Stage Ib-Iiia Nsclc.

JOURNAL OF CLINICAL ONCOLOGY(2011)

引用 5|浏览24
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要